Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors

被引:59
作者
López-Rodríguez, ML
Viso, A
Ortega-Gutiérrez, S
Lastres-Becker, I
González, S
Fernández-Ruiz, J
Ramos, JA
机构
[1] Univ Complutense, Fac Ciencias Quim, Dept Quim Organ 1, E-28040 Madrid, Spain
[2] Univ Complutense, Fac Med, Dept Bioquim & Biol Mol 3, E-28040 Madrid, Spain
关键词
D O I
10.1021/jm015545y
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In the present work, we have designed and synthesized a series of arachidonic acid derivatives of general structure I which have been characterized as highly potent and selective inhibitors of anandamide transporter (IC50 = 24-0.8 muM, K-i > 1000-5000 nM for CB1 and CB2 cannabinoid receptors and vanilloid VR1 receptor). Among them N-(3-furylmethyl)eicosa-5,8,11,14-tetraenamide deserves special attention as being the most potent endocannabinoid transporter inhibitor (IC50 = 0.8 muM) described to date.
引用
收藏
页码:4505 / 4508
页数:4
相关论文
共 38 条
[1]   Endocannabinoids control spasticity in a multiple sclerosis model [J].
Baker, D ;
Pryce, G ;
Croxford, JL ;
Brown, P ;
Pertwee, RG ;
Makriyannis, A ;
Khanolkar, A ;
Layward, L ;
Fezza, F ;
Bisogno, T ;
Di Marzo, V .
FASEB JOURNAL, 2001, 15 (02) :300-302
[2]   Cannabinoids control spasticity and tremor in a multiple sclerosis model [J].
Baker, D ;
Pryce, G ;
Croxford, JL ;
Brown, P ;
Pertwee, RG ;
Huffman, JW ;
Layward, L .
NATURE, 2000, 404 (6773) :84-87
[3]   Functional role of high-affinity anandamide transport, as revealed by selective inhibition [J].
Beltramo, M ;
Stella, N ;
Calignano, A ;
Lin, SY ;
Makriyannis, A ;
Piomelli, D .
SCIENCE, 1997, 277 (5329) :1094-1097
[4]   N-acyl-dopamines:: novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo [J].
Bisogno, T ;
Melck, D ;
Bobrov, MY ;
Gretskaya, NM ;
Bezuglov, VV ;
De Petrocellis, L ;
Di Marzo, V .
BIOCHEMICAL JOURNAL, 2000, 351 (03) :817-824
[5]   Bidirectional control of airway responsiveness by endogenous cannabinoids [J].
Calignano, A ;
Kátona, I ;
Désarnaud, F ;
Giuffrida, A ;
La Rana, G ;
Mackie, K ;
Freund, TF ;
Piomelli, D .
NATURE, 2000, 408 (6808) :96-101
[6]   Control of pain initiation by endogenous cannabinoids [J].
Calignano, A ;
La Rana, G ;
Giuffrida, A ;
Piomelli, D .
NATURE, 1998, 394 (6690) :277-281
[7]   RATIONALLY DESIGNED, POTENT COMPETITIVE INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS [J].
COREY, EJ ;
CASHMAN, JR ;
KANTNER, SS ;
WRIGHT, SW .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1984, 106 (05) :1503-1504
[8]   Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders [J].
De Petrocellis, L ;
Melck, D ;
Bisogno, T ;
Di Marzo, V .
CHEMISTRY AND PHYSICS OF LIPIDS, 2000, 108 (1-2) :191-209
[9]   Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity [J].
De Petrocellis, L ;
Bisogno, T ;
Davis, JB ;
Pertwee, RG ;
Di Marzo, V .
FEBS LETTERS, 2000, 483 (01) :52-56
[10]   ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR [J].
DEVANE, WA ;
HANUS, L ;
BREUER, A ;
PERTWEE, RG ;
STEVENSON, LA ;
GRIFFIN, G ;
GIBSON, D ;
MANDELBAUM, A ;
ETINGER, A ;
MECHOULAM, R .
SCIENCE, 1992, 258 (5090) :1946-1949